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Abstract
Osteochondral tissue engineering presents a current research challenge due to the necessity of combining both bone and cartilage
tissue engineering principles. In the present study, bilayered chitosan-based scaffolds are developed based on the optimization of both
polymeric and composite scaffolds. A particle aggregation methodology is proposed in order to achieve an improved integrative
bone–cartilage interface needed for this application, since any discontinuity is likely to cause long-term device failure. Cytotoxicity
was evaluated by the MTS assay with the L929 fibroblast cell line for different conditions. Surprisingly, in composite scaffolds using
unsintered hydroxyapatite, cytotoxicity was observed in vitro. This work reports the investigation that was conducted to overcome
and explain this behaviour. It is suggest that the uptake of divalent cations may induce the cytotoxic behaviour. Sintered hydroxyapatite
was consequently used and showed no cytotoxicity when compared to the controls. Microcomputed tomography (micro-CT) was carried
out to accurately quantify porosity, interconnectivity, ceramic content, particle and pore sizes. The results showed that the developed
scaffolds are highly interconnected and present the ideal pore size range to be morphometrically suitable for the proposed applications.
Dynamical mechanical analysis (DMA) demonstrated that the scaffolds are mechanically stable in the wet state even under dynamic com-
pression. The obtained elastic modulus was, respectively, 4.21 ± 1.04, 7.98 ± 1.77 and 6.26 ± 1.04 MPa at 1 Hz frequency for polymeric,
composite and bilayered scaffolds. Bioactivity studies using both a simulated body fluid (SBF) and a simulated synovial fluid (SSF) were
conducted in order to assure that the polymeric component for chondrogenic part would not mineralize, as confirmed by scanning elec-
tron microscopy (SEM), inductively coupled plasma-optical emission spectroscopy (ICP) and energy-dispersive spectroscopy (EDS) for
different immersion periods. The assays were carried out also under dynamic conditions using, for this purpose, a specifically designed
double-chamber bioreactor, aiming at a future osteochondral application. It was concluded that chitosan-based bilayered scaffolds pro-
duced by particle aggregation overcome any risk of delamination of both polymeric and composite parts designed, respectively, for chon-
drogenic and osteogenic components that are mechanically stable. Moreover, the proposed bilayered scaffolds could serve as alternative,
biocompatible and safe biodegradable scaffolds for osteochondral tissue engineering applications.
! 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Keywords: Osteochondral; Tissue engineering; Scaffolds; Particle aggregation; Chitosan
1. Introduction
Osteochondral defects are lesions of the articular carti-
lage where the underlying bone tissue is also damaged.
Currently, osteochondral defects are mostly treated by (i)
osteochondral autograft transfer, taken from an outer
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region of the joint [1]; (ii) filling the lesion with autologous,
precultured chondrocytes (autologous chondrocyte trans-
plantation, ACT) [2]; or (iii) matrix-induced autologous
chondrocyte implantation [3]. Although some studies have
achieved success in repairing small cartilage defects, no
accepted method for complete repair of osteochondral
defects exists [4]. Large osteochondral defects are associ-
ated with mechanical instability and are accepted indica-
tions for surgical intervention to prevent development of
degenerative joint disease. Ideally, a large osteochondral
defect should be repaired with a graft that can provide
mechanical stability and allow early postoperative function
under physiological loading conditions [5]. In addition, the
graft should integrate with the host tissue both structurally
and functionally, since any discontinuity can incite long-
term device failure [6].
The requirements for an osteochondral graft could
potentially be met by using a tissue-engineered osteochon-
dral (bone–cartilage) composite of predefined size and
shape, generated in vitro using autologous cells. Such a
graft would provide mechanical stability from the time of
implantation, minimize donor site morbidity by using cell
expansion techniques, and eliminate complications related
to the use of allografts and/or mechanical devices. The
bone region of the engineered osteochondral composite
may further help anchor the graft within the defect, since
a bone-to-bone interface integrates better and faster than
a cartilage-to-cartilage interface [6].
The overall objective of tissue engineering is the restora-
tion of normal tissue function. Ideally, lost or damaged tis-
sue should be replaced by an engineered graft that can re-
establish the appropriate structure, composition, cell sig-
nalling and function(s) of the native tissue [7]. The clinical
utility of tissue engineering likely depends on our ability to
replicate the site-specific properties of the tissue being
replaced across different size scales and provide the conti-
nuity and strength of the interface with the neighbouring
host tissues [8]. Therefore, for an osteochondral defect,
one should consider the need for simultaneous regeneration
of both cartilage and subchondral bone, making osteo-
chondral tissue engineering a challenge to present-day
research since it necessitates the combining of both bone
and cartilage tissue engineering principles.
Several possible strategies for developing hybrid con-
structs for osteochondral tissue engineering have been pub-
lished [5,9–11], namely: (i) cell culturing is performed
independently on two sides, which are integrated before
implantation; (ii) two different cell sources are seeded in
the two sides of a single- or double-phase scaffold, and cul-
tivated in a special bioreactor with two separated cham-
bers; and ideally (iii) common progenitor cells are seeded
in the two sides of a biphasic scaffold that contains different
differentiation agents and then cultivated in a bioreactor
with one or two chambers. For these, several bioreactors
have been described, as reviewed [8,12] and proposed [13]
by different authors. Bioreactor systems can provide the
technological means to reveal fundamental mechanisms
of cell function in a three-dimensional (3-D) environment
and the potential to improve the quality of engineered tis-
sues, providing environmental control, biochemical and
mechanical cues. Several bioreactor systems, such as rotat-
ing bioreactors and perfused cartridges or chambers, have
been used. Nevertheless, we believe that double-chamber
bioreactors [12,13] consisting of one chamber for the cul-
ture of the chondrogenic part and another chamber for
the osteogenic part, seems to be the most suitable for osteo-
chondral applications. The double-chamber bioreactor
should allow for the culture of chondrocytes, osteoblasts
or common progenitor cells in two different cell culture
media.
Many tissue engineering scaffolding strategies dealing
with osteochondral repair engage the design of bilayered
scaffolds that could regenerate both cartilage and subchon-
dral bone involving different combinations of materials,
morphologies and properties in both parts of the scaffold.
Nevertheless, some researchers suggest that osteochondral
defects could be regenerated from single-layer scaffolds
by seeding autologous chondrocytes at the top of the 3-D
scaffold to create a cell-scaffold construct for in vivo
implantation [14,15] or that complex tissue grafts could
be engineering with gradients of molecular, structural and
functional properties. Several strategies with single-layer
materials can be followed, as recently reviewed by Mano
and Reis [9]. Nevertheless, it is more widely accepted that
a bilayered structure would be more challenging to produce
but more suitable for regenerating an osteochondral defect
able to incorporate/induce different types of cells in a
favourable environment requiring different chemical sur-
roundings and mechanical requirements, leading to the
growth of two different tissues, with different biological
requirements.
Bearing this in mind, different approaches have been
reported. Swieszkowski et al. [4] proposed two different
systems using bone marrow-derived mesenchymal cells cul-
tured in chondrogenically and osteogenically favourable
conditions. The biphasic scaffolds consist of fibrin and
polycaprolactone (PCL) and PCL and PCL/b-tricalcium
phosphate (TCP), where the PCL-based scaffolds are fabri-
cated via fused deposition modelling (rapid prototyping
system). Both phases are fabricated and seeded separately,
then integrated into a single construct by using fibrin glue.
Their results demonstrate the potential of the porous PCL
and PCL-TCP scaffolds in promoting bone healing. Scotti
et al. [16] reported a biphasic composite made of an
expanded chondrocytes–fibrin glue gel composite with a
calcium phosphate scaffold. This paper focused mainly on
the problem of the neocartilage-to-bone integration, so
no cells were used in the osteogenic part of the biphasic
scaffold. Hence, the bilayered construct showed a triphasic
structure, with a cartilaginous zone, an intermediate zone
with the chondrocytes–fibrin glue complex penetrating
the calcium phosphate and a zone free from cells, made
of the remaining part of the calcium phosphate scaffold
[16].
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In the present study, particle aggregation methodology
is proposed to fabricate bilayered scaffolds for osteochon-
dral tissue engineering in order to achieve an improved
integrative bone and cartilage interface needed for this
application. Chitosan was chosen due to its structural sim-
ilarity to the glycosaminoglycans (GAGs) found in extra-
cellular matrices, such as native articular cartilage, which
play a key role in modulating the morphology, differentia-
tion and function of chondrocytes [17,18]. For the osteo-
genic part, composites with hydroxyapatite (HA) were
developed to mimic the bony structure. Glutaraldehyde
was used as a crosslinking agent to further improve the
mechanical performance. An extensive characterization is
reported, including in vitro cytotoxicity, morphometric
analysis and dynamic–mechanical behaviour in the
hydrated state. Furthermore, dynamic bioactivity assays
were carried out in a specifically designed double-chamber
bioreactor.
2. Materials and methods
2.1. Scaffolds production
The scaffolds were produced as described elsewhere
[19]. Briefly, chitosan (medium molecular weight and
!85% deacetylated) was ground and dissolved overnight
in acetic acid (1 vol.%) to obtain a chitosan solution
(2 wt.%). Unless otherwise stated, all chemicals were
bought from Sigma–Aldrich and used as received. In
composite particles production, 20 wt.% of unsintered
HA (Camceram II, coating powder, CAM Implants BV,
Leiden, The Netherlands) or sintered HA (Captal’s"
HA, Plasma Biotal Ltd., Tideswell, UK) was homoge-
neously dispersed in the chitosan solution. After complete
dissolution and filtration, the prepared solutions were
extruded through a syringe at constant rate (10 ml h"1)
to form chitosan droplets into a NaOH (1 M) precipita-
tion bath where particles with regular diameter were
formed. The chitosan particles were left in the precipita-
tion bath until precipitation was complete and then
washed repeatedly with distilled water until a pH of 7
was achieved.
For composite and bilayered scaffolds production, the
composite particles were submitted to a crosslinking reac-
tion with glutaraldehyde. For scaffold production optimi-
zation, different glutaraldehyde concentrations (0.01%,
0.025%, 0.05% and 0.5% for 15 min) were used. Scaffolds
were further washed with glycine solution (0.2 and 1 M
for 15 min) in order to block any free aldehyde groups.
After each step, scaffolds were washed with distilled
water. Unless otherwise stated, composite scaffolds were
crosslinked with 0.01% glutaraldehyde and washed with
1 M glycine, both for 15 min, as described in Table 1.
The particles were then pressed into moulds and left to
dry in an oven at 60 #C for 3 days. The scaffolds obtained
were of a cylindrical shape, 8 mm in height and 5 mm in
diameter.
2.2. Evaluation of cell viability
To assess the possible cytotoxicity of the developed scaf-
folds, the in vitro cell viability was assessed using MTS
assay (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxylmethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (Cell Titer 96"
AQueous Solution Cell Proliferation Assay, G3580, Pro-
mega, USA) according to ISO/EN 10993 part 5 guidelines,
which determines whether cells are metabolically active.
This cytotoxicity test is based on the bioreduction of the
substrate (MTS) into a brown formazan product by dehy-
drogenase enzymes in metabolically active cells, directly
related with cell viability. For this purpose, materials
(n = 3) were incubated in culture medium for 24 h at
37 #C with constant shaking after sterilization by ethylene
oxide (EtO) in conditions that have been described previ-
ously [20].
Latex was also incubated as a positive control for cell
death. A rat lung fibroblast cell line (L929) acquired from
the European Collection of Cell Cultures was used for
the studies. The cells were grown as monolayers in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented
with 10% foetal bovine serum (Biochrom, Berlin, Ger-
many; Heat Inactivated) and a 1% antibiotic–antimycotic
mixture. Cultured L929 cells were trypsinised using Tryp-
sin–EDTA (Gibco, Invitrogen Corporation) and plated
into 96-well micrometer plates (200 ll well"1) at 6.6 # 104
cells well"1. The plates were incubated for 24 h at 37 #C
in a humidified atmosphere of 5% CO2 in air. The medium
was then replaced by the previous prepared materials
extracts after sterilized by filtration (0.45 lm pore size)
using culture medium by itself as a negative control. After
72 h of incubation, the cell culture was treated with MTS
(in medium without phenol red) and incubated for a fur-
ther 3 h at 37 #C in a humidified atmosphere of 5% CO2
in air. At this stage, culture medium with MTS was trans-
ferred to new wells. The optical density, which is directly
proportional to the cellular activity (it reflects the mito-
chondrial activity), was read on a microplate reader (Syn-
ergy HT, BioTek Instruments) at 490 nm.
2.2.1. Inductively coupled plasma-optical emission
spectroscopy
Following the protocol for materials extracts performed
in the MTS assay, the different sample extracts solutions
were further analyzed in order to determine the concentra-
Table 1
Summary of scaffold abbreviations and composition.
Abbreviation Scaffolds Composition
Chitosan:HA
ratio
Glutaraldehyde
(%vv)
Glycine
[M]
C Polymeric 100:0 – –
CHA Composite 80:20 0.01%, 15 min 1 M,
15 min
BiCCHA Bilayered structures (polymeric + composite)
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tions of calcium, phosphorus, silicon, magnesium and
sodium elements. The element concentrations were mea-
sured by inductively coupled plasma-optical emission spec-
troscopy (ICP-OES JY70 plus, Jobin Yvon, France).
Triplicate samples were analyzed for each condition. For
this purpose, materials were incubated in DMEM for
24 h at 37 #C with constant shaking, after sterilization by
EtO in conditions that have been described previously
[20]. After that, the elemental concentrations of the pre-
pared materials extracts sterilized by filtration (0.45 lm
pore) were measured, using cell culture medium itself as
the control.
2.3. Microcomputed tomography
The scaffolds (n = 3) were analysed using microcomput-
ed tomography (micro-CT). Micro-CT was carried out
with a high-resolution micro-CT Skyscan 1072 scanner
(Skyscan, Kontich, Belgium) using a resolution of pixel
size of 7.53 lm and an integration time of 1.7 ms. The
X-ray source was set at 40 keV of energy and 250 lA of
current. Approximately 400 projections were acquired over
a rotation range of 180#, with a rotation step of 0.45#.
Data sets were reconstructed using standardized cone-
beam reconstruction software (NRecon v1.4.3, SkyScan).
The output format for each sample was 300 serial
1024 # 1024 bitmap images. Representative data sets of
200 slices were segmented into binary images with a
dynamic threshold of 40–255 to access the porosity and
150–255 to identify the ceramic phase (grey values). The
same representative volume of interest was analysed for
all the samples. These data sets were used for morphomet-
ric analysis (CT Analyser, v1.5.1.5, SkyScan) and to build
3-D models (ANT 3-D creator, v2.4, SkyScan). The mor-
phometric analysis included histograms of the scaffolds,
porosity and interconnectivity, mean pore and particle size,
pore size and ceramic phase distribution. Three-dimen-
sional virtual models of representative regions in the bulk
of the scaffolds were created, visualized and registered
using both image processing softwares (CT Analyser and
ANT 3-D creator).
2.4. Dynamical mechanical analysis
Dynamic mechanical analysis (DMA) was conducted in
order to characterize the mechanical behaviour of chitosan
particle-aggregated scaffolds in wet state, under dynamic
compression solicitation. Cylindrical chitosan-based scaf-
folds were immersed in phosphate-buffered solution
(PBS) at physiological pH and temperature (pH 7.4 and
37 #C) for 3 days for complete hydration. The scaffolds
were then were subjected to compression cycles of increas-
ing frequencies ranging from 0.1 to 40 Hz with constant
dynamic displacements of 0.03 mm using a Tritec2000
dynamic mechanical analyser (Triton Technology, UK).
Experiments were conducted at room temperature and five
points were measured within each decade. For each indi-
vidual scaffold, the data are averaged over three consecu-
tive runs. Five samples were measured for each type of
scaffolds. The real (storage modulus), E0, and the imaginary
component (loss modulus), E00, of the complex modulus,
E* = E0 + iE00 (with i = ("1)1/2), were recorded against fre-
quency. Reference values for comparison of the compres-
sion modulus were collected at a frequency of 1 Hz.
2.5. Static and dynamic bioactivity studies in a double-
chamber bioreactor
To study the in vitro bioactive behaviour (in vitro bone-
bonding ability [21]), two different simulated solutions were
used. A simulated body fluid (SBF) with ion concentrations
(Na+ 142.0, K+ 5.0, Mg2+ 1.5, Ca2+ 2.5, Cl" 103.0,
HCO3
2" 10.0, HPO4
2" 1.0 and SO4
2" 0.5 mm) [21,22] sim-
ilar to those of human blood plasma was prepared as
described elsewhere [21,22]. A simulated synovial fluid
(SSF) was also used to approximate the chemical environ-
ment in a human joint. SSF, with ion concentrations of
Na+ 153.1, K+ 4.2, Cl" 139.6 and phosphate buffer
9.6 mm [23], was prepared by dissolving 0.3 wt.% hyalu-
ronic acid in PBS to obtain a pH of 7.4. Hyaluronic acid
is a mucopolysaccharide composed of several thousand
amino-sugar residues, and is the primary diffuse macromol-
ecule that exists in human synovial fluid [23]. For the static
bioactivity tests, polymeric, composite and bilayered scaf-
fold samples (n = 3) were suspended and immersed in
50 ml of SBF and SSF separately at 37 #C and pH 7.4
(physiological conditions) for 0, 1, 3 and 14 days. After
soaking, the samples were immediately washed with dis-
tilled water and dried at room temperature. For the
dynamic bioactivity tests, a double-chamber bioreactor
was specially designed and set-up according to Fig. 1.
For these assays, bilayered scaffolds (n = 2) were assembled
in the bioreactor using a silicon septum. The SBF and SSF
were continuously circulated in physiological conditions
(pH 7.4 and 37 #C) using a peristaltic pump for up to
14 days with an available volume of 50 ml of each solution.
Scaffold and solution sampling was performed at 0, 3, 7
and 14 days.
The scaffold’s surface morphology, as well as the pres-
ence of elemental Ca and P on the scaffold’s surface, was
analysed both before and after soaking in SBF and SSF,
for the different experimental conditions at the different
immersion periods. This was done using scanning electron
microscopy (SEM) equipment (S360, Leica Cambridge
Ltd.) and energy-dispersive spectroscopy (EDS) equipment
(Link EXL II, Oxford) coupled to the SEM. Sample sur-
faces were carbon coated for EDS (Fisons Instruments,
Evaporation PSU CA508, UK) or gold sputtered for
SEM (Fisons Instruments, Sputter Coater SC502, UK).
Microphotographs and spectra were registered for further
analysis. Furthermore, the sample solutions were analysed
by ICP-OES in order to quantify the elemental concentra-
tions of Ca, P, Si, Mg and Na as function of the immersion
period.
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2.6. Statistical analysis
When applicable, statistical analysis of values obtained
with the characterization techniques was carried out using
Student’s two-tailed t-test with a confidence level of 99.5%.
All statistical calculations were performed with Analysis
ToolPak software. Values of p below 0.05 were considered
statistically significant.
3. Results and discussion
For osteochondral tissue engineering scaffolding, we
believe that a bilayered structure is the best approach, as
discussed in the introduction. For that, chitosan was cho-
sen as a natural, biodegradable polymeric matrix since it
is know that this polymer has a structural similarity to
the glycosaminoglycans (GAGs) found in natural extracel-
lular matrices, such as articular cartilage, where it plays a
key role in modulating the morphology, differentiation
and function of chondrocytes [17,18]. For the composite
component for the osteogenic part, HA was selected as a
filler since this is the main mineral present in the composite
structure of natural bone. In this way, it is expected that
both chitosan as the chondrogenic component and the
presence of HA for the osteogenic part will provide ade-
quate biochemical cues. Although the degradation of the
developed scaffolds is not within the scope of the present
paper, it should be mentioned that it has previously been
shown that chitosan particles degrade in vivo in a period
of 6 months [24], since chitosan is a natural biodegradable
polymer. It is true that crosslinking can increase the period
of degradation, but to demonstrate this influence in the
particular case of the developed chitosan particles, it would
be necessary to carry out in vivo studies.
3.1. Cytotoxicity assessment
Indirect contact tests, such as cytotoxicity tests with
MTS, are widely used as a preliminary screening for bio-
materials. These biological tests enable one to ensure that
the leachables from the materials will not induce any
in vitro cytotoxic effect on the cells. MTS tests were per-
formed in order to screen the eventual cytotoxicity of the
developed polymeric and composite scaffolds by means of
assessing the cell viability of L929 cells cultured with
extracts for 72 h. All the cell viability percentages plotted
in the following graphs are values relative to the control
(100% considered for L929 cells cultured with cell culture
medium). It was verified that extracts from the polymeric
chitosan scaffolds (C) did not affect the cellular viability,
since similar cellular viability was obtained as in the con-
trols, as shown in Fig. 2. However, and quite surprisingly,
it was found that composite scaffolds produced with unsin-
tered HA and crosslinked with glutaraldehyde reduced the
cell viability significantly even at low glutaraldehyde con-
centrations (Fig. 2A). Lower glutaraldehyde concentra-
tions were used since it was previously reported that
residual glutaraldehyde may induce a decrease in cell via-
bility due to free aldehyde groups [25]. Nevertheless, cross-
linking is desirable to improve the mechanical
performance. To try to overcome this problem, composite
scaffolds with unsintered HA crosslinked with 0.01% of
glutaraldehyde were treated with different glycine concen-
trations in order to block any residual free aldehyde groups
that could potentially induce this cytotoxic behaviour. The
cell viability increased after treatment with the higher con-
centration of glycine (1 M) independently of the treatment
time, even though it was found to be low (around 40%), as
shown in Fig. 2B.
From these results, one can conclude that the cytotoxic-
ity effect of the composite scaffolds was not being provoked
by the glutaraldehyde. Therefore, the unsintered HA was
replaced by sintered HA, which is more chemically stable.
The effect of both HAs was studied with no crosslinking
as a function of concentration. It was found that sintered
HA showed a significant increase in cell viability even for
such high concentrations as 20%, with no statistical differ-
ence from the control and polymeric scaffolds for this con-
centration. These MTS results are plotted in Fig. 3A. The
influence of glutaraldehyde concentration on composite
scaffolds with sintered HA was also investigated. No signif-
icant decrease in cell viability was observed for the majority
Fig. 1. Double-chamber bioreactor set-up (A). The double-chamber bioreactor consists in six interconnected double-chambers (B) where the different
solutions circulate in separate flow circuits. A silicon septum acts as the scaffold’s support (C and D). The schematically experimental conditions for the
dynamic bioactivity assays are represented in (D).
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of the conditions when compared to the controls and the
polymeric scaffolds, as shown in Fig. 3B. In general, when
using sintered HA, the obtained values for cell viability for
all formulations were completely acceptable for the pro-
posed applications. From these results, composite scaffolds
with 20 wt.% of sintered HA crosslinked with 0.01% glutar-
aldehyde and treated with 1 M glycine both for 15 min
were selected and used for further characterization studies,
since they have shown higher cell viability with no statisti-
cal difference from that of the controls and polymeric
scaffolds.
In order to try to understand the cytotoxic behaviour
induced by composite scaffolds with unsintered HA, ICP
was used to study the extracts from the materials after
immersion for 24 h in cell culture medium following the
MTS protocol and using the culture medium as control.
ICP results obtained for elemental Ca, Mg, Si and P con-
centrations are shown in Fig. 4. Interestingly, it was found
that when using composite scaffolds with unsintered HA,
the elemental Ca and Mg concentrations were statistically
lower than in composite scaffolds with sintered HA. When
both HAs are incorporated in a chitosan matrix, these ions
are taken up by the materials, indicating the formation of
an apatite-like layer, as discussed later. It is known that
apatites formed in a solution often replace the Ca2+ ion site
with small amounts of Mg2+, Na+ or K+ ions [26]. Thus,
from both ICP and MTS results one can say that this
uptake of Ca2+ and Mg2+ ions reached critically low values
for the composite scaffolds with unsintered HA, inducing
cytotoxic behaviour in these materials. It is known that
divalent cations, including Ca2+ and Mg2+, are active in
cell adhesion mechanisms, as further discussed elsewhere
[27–29].
Fibroblasts, like many other cell types, such as osteo-
blasts, chondrocytes and endothelial cells, are anchorage-
dependent cells [30], meaning that they need to adhere to
a substrate in order to maintain their function and viabil-
ity. Furthermore, it is known that cell–cell, cell–extracellu-
lar matrix and cell–substrate interactions are mediated by
integrins, which are cell adhesion receptors [31]. The extra-
cellular domains of these receptors possess binding sites for
a diverse range of protein ligands. Ligand binding is diva-
lent cation dependent and involves well-defined motifs in
the ligand [32]. Integrins can dynamically regulate their
Fig. 2. Cell viability evaluated by MTS assays of composite chitosan particle-aggregated scaffolds showing the influence of glutaraldehyde concentration
(A) and glycine treatment (B) when using unsintered HA. C stands for the polymeric scaffolds. *Statistically significantly different to controls and
polymeric scaffolds (C).
Fig. 3. Influence of unsintered and sintered HA (A) and glutaraldehyde concentrations with 1 M glycine treatment when using sintered HA (B) on cell
viability evaluated by MTS assays of composite chitosan particle-aggregated scaffolds. *Statistically significantly different to controls and polymeric
scaffolds (C).
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affinity for ligands; this is a key issue to their involvement
in processes such as cell adhesion or cell migration [32].
The cation composition of the extracellular milieu is a
potential regulatory factor as the binding of divalent cat-
ions to extracellular domains has been shown to activate
integrins [28], thereby activating the intracellular signalling
pathways. This divalent cation dependence for integrin
activation might explain why composite scaffolds produced
with unsintered HA showed cytotoxic behaviour. The
uptake of divalent cations led to critically low values to
be present in the material extracts, thereby compromising
cell adherence to the substrate.
In addition to integrins, cells express another Ca2+
-dependent molecule responsible for cell–cell adhesion.
The Ca2+-dependent group consists largely of a class of
transmembrane glycoproteins called cadherins. These
mediate cell–cell adhesion by homotypic protein–protein
interactions through their extracellular domain by forming
Ca2+ binding sites, which regulate cell adhesion [33]. In the
presence of Ca2+, E-cadherin (one subclass of cadherins)
resides principally in areas of cell–cell contact. In reduced
Ca2+, however, E-cadherin becomes susceptible to proteo-
lytic cleavage and rapidly loses function [34].
Several studies [27,29,35] have reported such divalent
cation-dependent behaviour. Paul et al. [29] investigated
the behaviour of MG63 osteoblast-like cells when cultured
in porous ceramic matrices from nanoparticles of calcium
phosphate containing zinc and magnesium. The study
showed that the presence of calcium and magnesium in
ceramic scaffolds encourages the cell adhesion and spread-
ing of osteoblasts cells onto the bioceramic matrices. In
another study, by Fugii et al. [27], the sensitivity to serine
proteinases of cellular proteins involved in cell–matrix
adhesion was investigated using C32 melanoma cells. The
treatment of cells with serine proteinases can effect inte-
grin-mediated attachment to matrix proteins in a manner
moderated by Ca2+. The study showed that in the absence
of Ca2+ reduced cell attachment was observed and that the
presence of this divalent cation had an additional effect
[27]. Furthermore, the divalent cation dependence of fibro-
blastic cell adhesion to a non-cellular substrate was also
demonstrated by Ueda et al. [35]. They showed that
Ca2+, Mg2+, Mn2+ and Co2+ were effective in promoting
the aggregation of fibroblastic cells, as well as their adhe-
sion to the non-cellular substrate.
In conclusion, one may say that the adhesion proteins
and their receptors together constitute a versatile recogni-
tion system, providing cells with anchorage, traction for
migration and signals for polarity, position, differentiation
and possibly growth [31]. Since these integrins require
divalent cations for ligand binding, one may justify the
cytotoxic behaviour of composite scaffolds produced with
unsintered HA based in the uptake of these divalent ions
to a critically low value. The low concentration of Ca2+
and Mg2+ may compromise the activation of integrins,
thereby affecting the adhesion of fibroblasts and, there-
fore, the cell viability when cultured with the material
extracts. However, as mentioned previously, this problem
was overcome by using sintered HA, which showed a cell
viability similar to that of the control and to the poly-
meric scaffolds.
3.2. Morphometric analysis
When aiming at osteochondral applications, the graft
should structurally and functionally integrate with the host
tissue, since any discontinuity is likely to cause long-term
device failure. To create constructs having more favourable
integration properties that might be used as osteochondral
tissue engineering scaffolds, we have successfully designed
and produced bilayered structures combining polymeric
and composite chitosan-based particles by promoting their
aggregation.
In order to assess the morphometric characterization
of the developed scaffolds, micro-CT was carried out.
The 3-D micro-CT technique provides a better under-
standing of the scaffold’s basic properties, thereby allow-
ing for the optimization of their design and the better
fulfilment of tissue engineering scaffolding needs. It is
thus a valuable instrument to support new fabrication
technologies. It provides accurate quantitative 3-D infor-
mation at the micro-level and in a non-destructive fash-
ion. This justifies its popularity in characterizing porous
scaffolds. Relevant morphometric parameters, such as
porosity, interconnectivity, pore and particle size, as well
as the ceramic and pore size distribution, can be retrieved
from this analysis.
The scaffold’s porosity and interconnectivity were
quantified and are shown in Fig. 5A. The mean total poros-
ity values of 27.78 ± 2.80%, 22.41 ± 2.79% and 31.49 ±
3.04% were obtained with an interconnectivity degree of
about 94.97 ± 1.40%, 91.77 ± 1.91% and 94.05 ± 2.43%
for the proposed polymeric, composite and bilayered
Fig. 4. Elemental Ca, Mg, Si and P concentrations of materials extracts
after a 24 h immersion in cell culture medium. *Statistically significant
difference between conditions. HA unsint. and HA sint. stand, respec-
tively, for unsintered and sintered hydroxyapatite; C stands for chitosan
polymeric scaffolds; and CHA stands for chitosan/hydroxyapatite com-
posite scaffolds. Medium is the control DMEM culture medium.
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scaffolds, respectively. It is important to stress that the
interconnectivity was calculated with a limit in the pore size
of 53 lm as the minimum value for interconnected pores,
meaning that interconnection diameters below this value
were considered as closed pores.
One interesting feature of the particle aggregation meth-
odology is that it does not compromise the scaffold’s inter-
connectivity, even at the interface (Fig. 5A). Since this
methodology is based on the random assembly of particles,
the bonding sites are the contact points of adjacent parti-
cles, thereby creating a highly interconnected network. As
a result, this strategy does not create any interface barrier
area, allowing further cell migration and nutrient flow
and thus potentially avoiding necrotic central regions.
Moreover, the values of porosity (Fig. 5A) that might be
considered low for tissue engineering applications [7,36]
are responsible for the high mechanical performance of
the materials, which is a critical issue when aiming at
load-bearing tissue engineering applications.
Pore size is another important morphological factor for
tissue ingrowth, and the scaffolds we developed have a wide
3-D pore size distribution in the range of the optimal pore
size, as indicated by different authors [37–39]. These results
are demonstrated in Fig. 6, which represents the number of
pores in each given size range for the different scaffolds for-
mulations. The mean values of pore diameter and particle
size (pore wall thickness) were found to vary between 225
and 290 lm and 410 and 460 lm, respectively, as shown
in Fig. 5B.
The different polymeric and ceramic phases present in the
samples are characterized by different values of the linear X-
ray attenuation coefficient. To obtain quantitative data for
each analysed scaffold, a histogram was generated plotting
the frequency of a given number of voxels as a function of
the X-ray absorption coefficient, as presented in Fig. 7A.
In the X-ray absorption histograms of the polymeric and
composite scaffolds, only one peak was observed for each
formulation, corresponding to the chitosan polymeric
phase and the chitosan-HA phase, respectively. The mean
of the peak related to the composite phase shifted to higher
values of linear attenuation coefficient due to the presence
of HA. In the case of the bilayered structure samples, both
Fig. 6. Distribution of pore size of polymeric, composite and bilayered chitosan particle-aggregated scaffolds measured by micro-CT. C, CHA and
BiCCHA are as for Fig. 4.
Fig. 5. Porosity and interconnectivity (A) and mean particle and pore size (B) of polymeric, composite and bilayered chitosan particle-aggregated scaffolds
measured by micro-CT. *Statistically significant difference between the two formulations. C, CHA and BiCCHA are as for Fig. 4.
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peaks were observed at lower and higher X-ray absorption
values, as expected, matching the polymeric and composite
phases that comprise this biphasic structure.
The ceramic phase content profile in the scaffolds was
also assessed and plotted against the scaffold thickness.
These results allow the evaluation of the ceramic distribu-
tion along the scaffold, including in the interface of the
bilayered structures (Fig. 7B). The steady increase in the
ceramic phase in the interface is clear evidence of the grad-
ual transition from the polymeric phase to the composite
structure.
The 3-D virtual models presented in Fig. 8 allow the
scaffolds’ interfaces to be visualized using different thresh-
olds to disclose the spatial distribution of both the poly-
meric and the ceramic matrix in the central part of the
scaffolds. From these images, we can see that good integra-
tion of both phases is achieved with this processing meth-
odology using chitosan as the polymeric matrix without
the need for any extra joining technique. This is due to
the bioadhesive properties of chitosan [40]. One can con-
clude that a successful approach was achieved by means
of assembling polymeric and composite chitosan-based
particles in order to fabricate an integrated two-phase scaf-
fold for osteochondral tissue engineering.
3.3. Dynamical–mechanical behaviour
As discussed previously, large osteochondral defects are
associated with mechanical instability [5]. Therefore, the
mechanical properties of the scaffold or engineered tissue
before implantation into an osteochondral defect are key
determinants of its long-term success or eventual failure.
Furthermore, the mechanical properties of a scaffold will
influence the mechanical environment of the seeded cells
[41].
When designing a complex osteochondral construct, it is
desirable that the heterogeneous structures be built in such
a way that one of the sides promotes cartilage regeneration
and the other side, exhibiting different properties, supports
bone integration. For example, the cartilage-side layer
should be more ductile and should have a much greater
fluid uptake capability [9]. However, it is predicted that
increasing the stiffness of the scaffold to a certain level
increases the amount of cartilage formation and reduces
the amount of fibrous tissue formation in the defect [41].
The bone-side layer should exhibit greater stiffness, should
preferably have a good affinity to the ceramic constituent
of bone and, ideally, should be able to induce vasculariza-
tion, especially for large defects [9].
In the present study, bilayered structures were designed
with these considerations in mind. For the chondrogenic
part, chitosan polymeric particles were assembled while
for the osteogenic constituent composite particles were
used with HA as a ceramic filler and were further cross-
linked with glutaraldehyde in order to improve the compo-
nent’s stiffness. The assessment of the scaffold’s mechanical
behaviour is essential to demonstrate its mechanical stabil-
ity, namely in dynamic conditions and in a hydrated state
resembling the conditions in vivo, where physiological flu-
ids are present. For that purpose, chitosan-based scaffolds
were fully hydrated in PBS for 3 days in physiological con-
ditions, based on previous hydration studies which showed
that after this time period a hydration plateau was achieved
(data not shown). Chitosan-based particle-aggregated scaf-
folds in this wet state were then characterized under
dynamic compression over a range of physiological fre-
quencies in load-bearing applications, such as articular car-
tilage or bone [14,42]. The values at a frequency of 1 Hz
were considered as reference values for comparisons of
the elastic (storage) and viscous (loss) components of the
complex modulus, and are shown in Fig. 9A.
From these results, we can first conclude that the scaf-
folds showed very good mechanical properties compared
to those obtained for chitosan-based porous materials
[43,44], even if only considering the polymeric formulation.
The mean values for the elastic component (E0) were found
to be 4.21 ± 1.04, 7.98 ± 1.77 and 6.26 ± 1.04 MPa for
polymeric, composite and bilayered scaffolds, respectively.
The high mechanical properties obtained by the particle
aggregation methodology are further supported by the
findings of another study, namely that of Jiang et al. [45],
who used chitosan microspheres with poly(lactic acid–gly-
colic acid) sintered together to obtain the final 3-D struc-
ture. E0 was further increased for the composite scaffolds
Fig. 7. Representative X-ray absorption histogram (A) and ceramic content distribution (B) obtained for polymeric, composite and bilayered chitosan
particle-aggregated scaffolds. C, CHA and BiCCHA are as for Fig. 4.
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Fig. 8. Three-dimensional virtual models of chitosan particle-aggregated scaffolds: polymeric (C; A), composite (CHA; B, D and F) and bilayered
(BiCCHA; C, E and G) scaffolds, showing the gradual transition (D and E) that shows the ceramic phase distribution (F and G).
Fig. 9. Storage (E0) and loss (E0 0) moduli under dynamic compression solicitation at 1 Hz frequency (A) and behaviour for increasing frequencies (B, C
and D) of polymeric (C), composite (CHA) and bilayered (BiCCHA) chitosan particle-aggregated scaffolds in the wet state. The inset graphs show the
frequency dependence of the loss factor (tand). *Statistically significantly different compared to the polymeric scaffolds.
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by incorporating HA and crosslinking the polymeric
matrix to obtain a scaffold with greater stiffness, as envi-
sioned for the osteogenic component. A twofold increase
in E0 was achieved and, as expected, the bilayered materials
presented an intermediate value between the polymeric and
composite scaffolds since they are both the basis of its
structure.
In addition, the storage (E0) and loss (E00) modulus
behaviours for increasing frequencies are presented in
Fig. 9B–D, with the frequency dependences of the loss fac-
tor (tand) shown in the inset graphs. As can be seen, the
developed materials showed the same profiles for storage
(E0) and loss (E00) moduli with increasing frequencies. The
elastic modulus (E0) increases with increasing frequency,
being typically between 4 and 9 MPa, while the viscous
modulus (E00) shows the inverse trend, increasing for higher
frequencies, this behaviour being more obvious for com-
posite materials.
As a consequence, there is a decrease in the loss factor
(tand = E00/E0) with increasing frequency, with a slight
increase for higher frequencies, as shown in the inset
graphs. This factor measures the proportion of the imposed
mechanical stress that is dissipated in the form of heat. As
tand is typically above 0.08 for f < 1 Hz, one may conclude
that the scaffolds possess significant damping capability,
which may be useful in dissipating some of the cyclic
mechanical energy that is imposed in an implantation sce-
nario. Nevertheless, there is an increase in E00 for high fre-
quencies, which suggests that the material exhibits some
dissipation capability for high frequencies.
By dynamically testing the bilayered scaffolds in wet
conditions in a physiological range of frequencies, we were
able to demonstrate that these biphasic materials are
mechanically stable even for higher frequencies, showing
once again the high level of integration between the two
components.
3.4. Static and dynamic in vitro bioactivity studies
The in vitro bioactivity studies were performed to
address two hypotheses, since we are discussing the poten-
tial application in osteochondral tissue engineering. On one
hand, one should assure that the polymeric component
designed for the chondrogenic part will not mineralize even
with the extra supply of Ca and P from the composite com-
ponent. To preliminarily screen this behaviour, SSF was
also used in order to mimic the chemical environment of
a human joint. On the other hand, we needed to evaluate
the ability for the composite component designed for the
osteogenic part to form per se an apatite layer on its sur-
face. This can predict the bone-bonding ability of the mate-
rial, which is often evaluated in SBF [21].
For this, the osteogenic component was designed as a
polymer composite, which includes a bioactive ceramic
phase (HA) as the source of both bioactivity and reinforce-
ment incorporated into the polymeric matrix. The compos-
ite component thus potentially has the capability of
combining bioactive behaviour with improved mechanical
performance, as discussed previously. This strategy was
first used to produce HA–polyethylene bioactive compos-
ites [46], and was also applied to develop composites con-
taining other bioactive phases, such as bioactive glasses
[47] and glass ceramics [48], and a series of different poly-
mers [46,47,49].
To address both hypotheses, in vitro bioactivity studies
were carried out using two different simulated solutions
(SBF and SSF) in both static and dynamic conditions.
The aim of the dynamic strategy was to approach the ideal
scenario required to engineer in vitro an osteochondral
construct.
The SEM microphotographs for static conditions are
disclosed in Fig. 10, where it is possible to analyse the scaf-
fold’s surface before and after 14 days of immersion in
both SBF and SSF. In the figure, no significant morpholog-
ical changes could be seen in the scaffold’s surface, even
after 14 days of immersion in both simulated solutions.
In the case of composite components, this may be due to
the presence of HA already in the surface, which makes
it very irregular and so could mask any apatite formation.
However, from the ICP results (Fig. 11) there is a clear
evidence of the Ca and P concentration decrease in the
solution from both composite and bilayered scaffolds indi-
cating that these materials are consuming these ions for an
apatite formation. As can be seen, a sharp decrease in the
Ca concentration of SBF (Fig. 11A) takes place in the first
7 days of immersion for composite and bilayered samples,
stabilizing at a certain value up to 14 days. The same trend
is observed for the P concentration (Fig. 11B), which
becomes stable after 3 and 7 days for SSF and SBF,
respectively.
Interestingly, ICP revealed the selective absorption of Ca
and P for the bilayered structures, since these materials show
a higher amount of both Ca and P present in solution when
compared to composite samples. This selective absorption
was further confirmed by EDS (Fig. 12), with no Ca and P
being detected at the surface of the polymeric component
after 14 days of immersion in both solutions (Fig. 12B). In
addition, an increase in the Ca and P peak intensity for the
composite constituent can be observed, which becomes even
clearer when immersed in SBF (Fig. 12C).
From these results, one can conclude that both hypoth-
eses were addressed, since in static conditions the polymeric
component designed for the chondrogenic part did not
mineralized in vitro and the composite part consumes both
Ca and P from the simulated solutions to form an apatite
layer.
To study the in vitro bioactivity in dynamic conditions,
we designed a specific double-chamber bioreactor (see
Fig. 1). The ultimate goal is for this design to be used in
future studies to engineer bilayered hybrid constructs for
osteochondral applications. For this, the bioreactor was
designed to allow the simultaneous culturing of chondro-
cytes and osteoblasts in the respective sections of a sin-
gle-unit chamber.
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The scaffolds are supported by a transversal silicon
membrane and both simulated solutions (SBF and SSF)
are continuously recirculated in the six interconnected
chambers in each respective part of the bilayered scaffold.
This also promotes dynamic perfusion and a laminar flow
in each of the bioreactor compartments, thereby contribut-
Fig. 10. SEM microphotographs of scaffolds surface before (A, D, G and J) and after 14 days of immersion in SBF (B, E, H and L) and SSF (C, F, I and
M) in static conditions. C stands for polymeric scaffolds (A, B and C), CHA for composite scaffolds (D, E and F), BiCCHA pol for the surface of the
polymeric part (G, H and I) and BiCCHA comp for the surface of the composite part (J, L and M) of the bilayered scaffolds. The bar scale represents
50 lm.
Fig. 11. Calcium (A) and phosphorous (B) concentration profiles of SBF and SSF as a function of immersion time of polymeric (C), composite (CHA)
and bilayered (BiCCHA) scaffolds in static conditions.
P.B. Malafaya, R.L. Reis / Acta Biomaterialia 5 (2009) 644–660 655
ing to enhanced cell distribution and the mass transfer of
nutrients and avoiding the potential necrotization of the
central regions. SBF has a flow circuit through the compos-
ite parts of the bilayered structures while SSF circulates
through the polymeric part designed for the chondral con-
stituent to approximate the chemical environment in a
human joint.
Similarly to the static conditions, the SEM microphoto-
graphs of the dynamic assays did not show any significant
morphological changes in either the polymeric or the com-
posite surfaces of the bilayered scaffolds, as shown in The
concentration profiles of Ca and P of both simulated solu-
tions (SBF and SSF) in the double-chamber bioreactor
assessed by ICP analysis are shown in Fig. 14. Through
the first 7 days, the Ca concentration of SBF decreased sig-
nificantly from 100 to around 40 mg l"1 (Fig. 14A). The Ca
concentration then seems to stabilize. An inverse profile is
observed for the Ca concentration of SSF, with a clear
increase within the first 3 days that becomes less attenuated
over longer periods. Exactly the same trend profile is
observed for the P concentration (Fig. 14B), only in this
case the SSF solution supplies P to the SBF. This is an indi-
cation of the ion exchange between both simulated solu-
tions in the double-chamber bioreactor.
We calculated and compared the consumption of Ca
and P of the bilayered structures by subtracting the con-
stant initial value from the total concentration at a given
time period (dashed grey line in Fig. 13). It can be seen that
the consumption of Ca gradually increases up to 7 days,
before stabilizing. The same trend is observed for the P
concentration, with a tendency to increase slightly after
3 days of immersion. This consumption data clearly indi-
cate that the Ca and P are being captured by the materials,
which is one of the criteria for the evaluation of the in vitro
bioactivity of materials.
These results were further complemented by EDS anal-
ysis (Fig. 15), which showed that neither Ca nor P was
detected at the surface of the polymeric component after
14 days in the double-chamber bioreactor and showed an
increase in the Ca and P intensity peaks for the composite
part even after only 3 days. This is clear evidence that these
ions are being selectively consumed by the composite part
of the bilayered structures.
The studies with the double-chamber bioreactor show its
potential since the scaffolds were able to withstand the per-
fusion rates. With the proposed design, the medium flow
direction can be inverted at certain interval periods, in
order to promote increased homogeneity and charge distri-
bution. Ion exchange between the two simulated solutions
was observed due to the high interconnectivity of the devel-
oped scaffolds that allowed the solutions to exchange with
time. This can be considered as a disadvantage when aim-
ing to engineer an osteochondral hybrid construct using the
same source of progenitor cells with different differentiation
cell culture media, or the simultaneous but independent
culturing of chondrocytes and osteoblasts.
Nevertheless, we have to consider that in cell culture
assays the culture media are frequently mixed to supply
the adequate concentration of nutrients. Furthermore, if
desirable, the materials can be designed with a physical
barrier between the chondrogenic and osteogenic compo-
nents without compromising the integration of the scaf-
folds. In the case of chitosan-based materials, a chitosan
membrane can be assembled when producing the materi-
als since this polymer is known to be bioadhesive [40].
Furthermore, as one of the ongoing strategies with
chitosan-based particle-aggregated scaffolds, the physical
barrier can be accomplished using a hydrogel for the
chondrogenic component where chondrocytes can be
encapsulated.
Fig. 12. EDS spectra showing the presence of calcium and phosphorous in the surface of polymeric scaffolds (A), polymeric part of bilayered scaffolds
(BiCCHA pol; B) and ceramic part of bilayered scaffolds (BiCCHA comp; C) before and after 14 days of immersion in SBF and SSF in static conditions.
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Alternatively, some authors [8,50,51] defend the applica-
tion of a single-phase material, but with gradients of molec-
ular, structural and functional properties, to engineer
complex tissue grafts, as discussed in the introduction. As
an example, Vunjak-Novakovic et al. [8] proposed a sin-
gle-phase silk-based scaffold which is functionalized by
covalently binding growth factors with spatial concentra-
tion gradients, with opposing gradients of a chondrogenic
factor (IGF-I) and an osteogenic factor (BMP-2) for tissue
engineering of osteochondral grafts. The opposite gradi-
ents of these two different growth factors in the same scaf-
fold are proposed in order to mimic the ‘‘ideal”
concentration of IGF-I for cartilage at one end and the
‘‘ideal” concentration of BMP-2 for bone at the other
end [8].
It is possible for the double-chamber bioreactor, or the
materials to be used within it, to be further optimized in
future studies for engineer osteochondral hybrid con-
structs. Nevertheless, in the present study, a double-cham-
ber bioreactor was successfully designed to study the
in vitro bioactivity behaviour in dynamic conditions.
4. Conclusions
By using a simple particle aggregation method, it was
possible to obtain bilayered chitosan-based scaffolds that
Fig. 13. SEM microphotographs of scaffolds surface before (A and B) and after 3 (C and D), 7 (E and F) and 14 days (G and H) of dynamic bioactivity
assay in the double-chamber bioreactor where SBF and SSF were circulating. BiCCHA pol stands for the surface of the polymeric part (A, C, E and G)
while BiCCHA comp stands for the surface of the composite part (B, D, F and H) of the bilayered scaffolds. The bar scale represents 50 lm.
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exhibit very promising properties for osteochondral appli-
cations. The risk of possible delamination between both
polymeric and composite components designed for chon-
drogenic and osteogenic constituents, respectively, was
avoided since the materials showed an integrated interface
assessed by micro-CT, as well as mechanical stability in the
wet state under dynamic compression. It is suggested that
the unexpected cytotoxic behaviour of composite materials
produced with unsintered HA could be explained by the
critically low concentrations of Ca and Mg found in the
extracts. This low divalent cation concentration might
affect the activation of integrins, compromising the cell
adhesion and, therefore, the cell viability. This unexpected
result was overcome by means of using sintered HA, which
showed no cytotoxic behaviour. From the overall results of
the in vitro bioactivity assays, both addressed hypotheses
were corroborated, since in static conditions the polymeric
component designed for the chondrogenic part did not
mineralized in vitro and the composite part selectively con-
sumes both Ca and P from the simulated solutions to form
an apatite layer. Furthermore, a specific double-chamber
bioreactor was successfully designed for in vitro bioactivity
tests in dynamic conditions, also aimed at use in future
studies to engineer osteochondral hybrid constructs.
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